The newly-spun out drug business, Baxalta — which is building a 500-employee research and development in Cambridge — is reportedly in talks to buy one of the most longstanding biotechs in the state, Ariad Pharmaceuticals. Bloomberg …
The most recent short interest data has been released by the NASDAQ for the 07/31/2013 settlement date, which shows a 2,230,507 share increase in total short interest for ARIAD Pharmaceuticals, Inc. (NASD: ARIA), to 18,217,590, an …
The most recent short interest data has been released for the 01/13/2017 settlement date, which shows a 8,224,965 share decrease in total short interest for ARIAD Pharmaceuticals Inc (NASDAQ:ARIA), to 23,605,983, a decrease of 25.84% …
Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want? Stocks that look great based on one factor may prove horrible elsewhere, making due …
AOL5y
And then we think of little Aria, who will not remember the frightful scene ... missing analysts' consensus estimates of $0.61 by $0.03. A certain stock may be …
Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F …
I'm a new Aria user, and I've pretty much got everything setup for Exchange access via ActiveSync. I am able to set the stock HTC e-mail client to receive HTML formatted messages from our Exchange server, which is great. However, I get …
Do not stay at the Aria Resort and Casino. It's a rip-off ... plus the invaluable Crotty on Education Stock Index. You can subscribe to Crotty Newsletters here.
BOSTON (MarketWatch) -- Shares of Ariad Pharmaceuticals aria fell 9% in early action Tuesday after the biotech group priced a common stock offering almost 10% below Monday's closing price. Ariad said it plans to sell up to 18.4 million …